Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
105.16B
Market cap105.16B
Price-Earnings ratio
18.29
Price-Earnings ratio18.29
Dividend yield
4.01%
Dividend yield4.01%
Average volume
3.26M
Average volume3.26M
High today
$43.50
High today$43.50
Low today
$43.05
Low today$43.05
Open price
$43.31
Open price$43.31
Volume
390.36K
Volume390.36K
52 Week high
$52.68
52 Week high$52.68
52 Week low
$40.89
52 Week low$40.89

SNY News

TipRanks 17h
Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...

Benzinga 4d
Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug

The approval makes Sarclisa Escena the first anticancer therapy that can be administered through both an on-body injector (OBI) and manual subcutaneous injectio...

Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug
TipRanks 4d
Sanofi’s iGlarLixi Diabetes Trial Nears Readout: What Investors Should Watch

Sanofi (SNYNF) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more con...

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

More SNY News

TipRanks 4d
Sanofi announces subcutaneous Sarclisa Escena approved in U.S.

The U.S. Food and Drug Administration has approved subcutaneous Sarclisa Escena in combination with standard-of-care regimens for the treatment of patients with...

TipRanks 6d
Sanofi price target lowered to $49 from $52 at Morgan Stanley

Morgan Stanley analyst Sarita Kapila lowered the firm’s price target on Sanofi (SNY) to $49 from $52 and keeps an Equal Weight rating on the shares. Sanofi appe...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.